Intelligent Bio Solutions IncNASDAQ:INBS
- LAST PRICE1.4800
- TODAY'S CHANGE (%)-0.0400 (-2.6316%)
- Bid / Lots1.4800/ 6
- Ask / Lots1.6100/ 1
- Open / Previous Close1.5100 / 1.5200
- Day Range
- 52 Week Range
- Volume95,812
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | INBS |
|---|---|---|
| 09:32 ET | 1625 | 1.5152 |
| 09:33 ET | 100 | 1.5 |
| 09:35 ET | 1292 | 1.5074 |
| 09:42 ET | 100 | 1.505 |
| 09:44 ET | 1387 | 1.5 |
| 09:46 ET | 363 | 1.5001 |
| 09:50 ET | 5000 | 1.5002 |
| 09:51 ET | 3100 | 1.505 |
| 09:55 ET | 100 | 1.5001 |
| 10:00 ET | 1000 | 1.5053 |
| 10:08 ET | 2400 | 1.5 |
| 10:11 ET | 100 | 1.51 |
| 10:13 ET | 142 | 1.5062 |
| 10:22 ET | 15629 | 1.5 |
| 10:24 ET | 1000 | 1.49 |
| 10:26 ET | 639 | 1.5 |
| 10:31 ET | 298 | 1.495 |
| 10:38 ET | 366 | 1.4901 |
| 10:45 ET | 227 | 1.49 |
| 10:51 ET | 998 | 1.4615 |
| 10:54 ET | 1300 | 1.452 |
| 10:56 ET | 3905 | 1.46 |
| 10:58 ET | 2000 | 1.4604 |
| 11:03 ET | 400 | 1.46 |
| 11:05 ET | 200 | 1.46 |
| 11:07 ET | 7235 | 1.4673 |
| 11:12 ET | 300 | 1.47 |
| 11:16 ET | 100 | 1.47 |
| 11:18 ET | 300 | 1.4669 |
| 11:23 ET | 2850 | 1.47 |
| 11:27 ET | 100 | 1.46 |
| 11:41 ET | 400 | 1.4501 |
| 11:43 ET | 100 | 1.47 |
| 11:50 ET | 100 | 1.46 |
| 11:56 ET | 4916 | 1.4501 |
| 12:01 ET | 200 | 1.4501 |
| 12:03 ET | 100 | 1.45 |
| 12:10 ET | 1900 | 1.46 |
| 12:12 ET | 100 | 1.455 |
| 12:15 ET | 100 | 1.46 |
| 12:35 ET | 100 | 1.455 |
| 12:37 ET | 1000 | 1.46 |
| 12:39 ET | 200 | 1.455 |
| 01:00 ET | 100 | 1.455 |
| 01:06 ET | 100 | 1.45 |
| 01:24 ET | 6300 | 1.45 |
| 01:26 ET | 139 | 1.455 |
| 01:33 ET | 1990 | 1.45 |
| 01:40 ET | 300 | 1.455 |
| 01:45 ET | 100 | 1.455 |
| 01:54 ET | 100 | 1.46 |
| 02:07 ET | 100 | 1.46 |
| 02:14 ET | 200 | 1.4509 |
| 02:18 ET | 100 | 1.46 |
| 02:21 ET | 426 | 1.45 |
| 02:38 ET | 5000 | 1.4502 |
| 02:41 ET | 100 | 1.46 |
| 03:15 ET | 687 | 1.455 |
| 03:17 ET | 500 | 1.46 |
| 03:21 ET | 400 | 1.47 |
| 03:33 ET | 536 | 1.475 |
| 03:37 ET | 100 | 1.4843 |
| 03:55 ET | 112 | 1.475 |
| 03:57 ET | 875 | 1.485 |
| 04:00 ET | 1052 | 1.48 |
Nov 13, 2024
Intelligent Bio Solutions Announces Positive Results of PK Study, a Key Milestone on Path to FDA 510(k) Submission, from 8:30AM ET on Wednesday Nov 13, 2024 by Dow Jones
8:30AM ET on Wednesday Nov 13, 2024 by Dow Jones
Nov 7, 2024
Intelligent Bio Solutions Reports Fiscal 2025 First Quarter Financial Results and Operational Highlights, from 8:30AM ET on Thursday Nov 07, 2024 by Dow Jones
8:30AM ET on Thursday Nov 07, 2024 by Dow JonesPress Release: Intelligent Bio Solutions Reports Fiscal 2025 First Quarter Financial Results and Operational Highlights, from 8:30AM ET on Thursday Nov 07, 2024 by Dow Jones
8:30AM ET on Thursday Nov 07, 2024 by Dow Jones
Nov 1, 2024
Intelligent Bio Solutions Partners With B2i Digital to Amplify Investor Outreach, from 7:34PM ET on Friday Nov 01, 2024 by Dow Jones
7:34PM ET on Friday Nov 01, 2024 by Dow Jones
Oct 31, 2024
Intelligent Bio Solutions Partners with B2i Digital to Amplify Investor Outreach, from 8:30AM ET on Thursday Oct 31, 2024 by Dow Jones
8:30AM ET on Thursday Oct 31, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Intelligent Bio Solutions Inc | 6.5M | -0.1x | --- |
Xenetic Biosciences Inc | 5.7M | -1.2x | --- |
Trevena Inc | 1.5M | 0.0x | --- |
HCW Biologics Inc | 11.1M | -0.3x | --- |
Senti Biosciences Inc | 9.8M | -0.1x | --- |
Aridis Pharmaceuticals Inc | 4.5K | 0.0x | --- |
Company Information
Intelligent Bio Solutions Inc. is a medical technology company focused on developing and delivering intelligent, rapid, non-invasive testing and screening solutions. Its segment includes Commercially available Intelligent Fingerprinting Products and Development Stage Biosensor Platform Technology. Its product portfolio includes Intelligent Fingerprinting Platform that analyzes fingerprint sweat using a one-time cartridge and portable handheld reader, and a two-part system that consists of non-invasive, fingerprint sweat-based diagnostic testing products designed to detect drugs of abuse including opiates, cocaine, methamphetamines, benzodiazepines, cannabis, methadone, and buprenorphine. The Biosensor Platform is designed to detect multiple biological analytes by substituting the top enzyme layer of the biosensor to suit each analyte and to develop a range of Point of Care Tests, including the modalities of clinical chemistry, immunology, tumor markers, allergens, and endocrinology.
Contact Information
- Headquarters
- 135 W 41St St,, Floor 5NEW YORK, NY, United States 10036
- Phone
- 646-233-6971
- Fax
- 302-575-1642
Executives
- Chairman of the Board
- Steven Boyages
- President, Chief Executive Officer
- Harry Simeonidis
- Chief Financial Officer
- Spiro Sakiris
- Independent Director
- Lawrence Fisher
- Independent Director
- Nicola Fraser
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $6.5M |
|---|---|
Revenue (TTM) | $3.2M |
Shares Outstanding | 4.4M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 4.73 |
EPS | $-27.94 |
Book Value | $2.41 |
P/E Ratio | -0.1x |
Price/Sales (TTM) | 2.0 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -328.80% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
